Retinal vascular occlusion syndromes

International Ophthalmology Clinics

Volumn 49, Issue 3, 2009, Pages 63-79

  Haymore, Jonathan G ^a   Mejico, Luis J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN INHIBITOR;

ARGON PLASMA COAGULATION; BLURRED VISION; BODY MASS; BRAIN DISEASE; BRANCH RETINAL ARTERY OCCLUSION; BRANCH RETINAL VEIN OCCLUSION; CARDIOVASCULAR DISEASE; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; DRUG MEGADOSE; EYE PAIN; GIANT CELL ARTERITIS; GLAUCOMA; HEARING LOSS; HEMI CENTRAL RETINAL VEIN OCCLUSION; HUMAN; HYPERTENSION; IRIS RUBEOSIS; LASER COAGULATION; OCULAR ISCHEMIC SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RADIAL OPTIC NEUROTOMY; RETINA BLOOD VESSEL OCCLUSION; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; RISK FACTOR; SUSAC SYNDROME; TRANSITIONAL BLINDNESS; VEIN ANASTOMOSIS; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VITRECTOMY;

BLINDNESS; EYE; GIANT CELL ARTERITIS; HUMANS; ISCHEMIA; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; SYNDROME;

EID: 68949156177     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181a8db88     Document Type: Review

References (129)

1. Leber T. Die Krankheite der Netzhaut und des Sehnerven. In: Graefe A, Saemisch T. eds. Handbuch der Gesamten Augenheikunde. Leipzig: Verlag von Wilhelm Engelmann; 1877:531.
2. Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-141.
3. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1243-1247. (Pubitemid 26338856)
4. Lang GE, Freissler K. Clinical and fluorescein angiography findings in patients with retinal vein occlusion. A unicenter study of 211 patients. Klin Monatsbl Augenheilkd. 1992;201:234-239.
5. The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. AmJ Ophthalmol. 1993; 116:286-296.
6. Frangieh GT, Green WR, Barraquer-Somers E, et al. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100:1 132-1140.
7. Duker JS, Brown GC. Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol. 1989; 107:998-1000.
8. Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology. 1993;100:423-428.
9. Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999; 106:2054-2062.
10. Remky A, Arend O, Jung F, et al. Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefes Arch Clin Exp Ophthalmol. 1996;234 (suppl 1):S8-S12.
11. Kuhli C, Scharrer I, Koch F, et al. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. AmJ Ophthalmol. 2004; 137:459-464.
12. Kadayifçilar S, Ozatli D, Ozcebe O, et al. Is activated factor VII associated with retinal vein occlusion? BrJ Ophthalmol. 2001;85:1174-1178.
13. Greiner K, Hafner G, Dick B, et al. Retinal vascular occlusion and deficiencies in the protein C pathway. AmJ Ophthalmol. 1999; 128:69-74.
14. Banik S, Bhutto HU, Bagga P. Recurrent branch retinal vein occlusion with factor V leiden mutation. Eye. 2006;20:948-949.
15. Gutman FA, Zegarra H, Zakov ZN. The natural course of temporal retinal vein occlusion. Trans Am Acad Opthalmol Otolaryngol. 1974;78:178-192.
16. Michels RG, Gass JDM. Natural course of temporal retinal branch occlusion. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:166-177.
17. Wetzig PC. The treatment of acute branch vein occlusion by photocoagulation. AmJ Ophthalmol. 1979;87:65-73.
18. Jalkh AE, Avila PM, Zakka KA, et al. Chronic macular edema in retinal branch vein occlusion: role of laser photocoagulation. Ann Ophthalmol. 1984; 16:526-533.
19. Subramanian ML, Heier JS, Esrick E, et al. Preoperative visual acuity as a prognostic indicator for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2006;37:462-467.
20. Lang GE, Handel A. Results of laser coagulation of retinal branch vein occlusion. Klin Monatsbl Augenheilkd. 1993;203:180-188.
21. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and hemorrhage in branch vein occlusion. Arch Ophthalmol. 1986;104:34-41.
22. Gutman FA. Macular edema in branch retinal vein occlusion: Prognosis and management. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:488-493.
23. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983;90:488-506.
24. Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 1986;93:975-977.
25. The Branch Retinal Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusions. AmJ Ophthalmol. 1984;98:271-282.
26. Jonas JB, Akkoyun I, Kamppeter B, et al. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 2005; 19:65-71. (Pubitemid 40192642)
27. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand. 2005;83:600-604. (Pubitemid 41488636)
28. Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina. 2005;25:856-860. (Pubitemid 41456576)
29. Bakri SJ, Shah A, Falk NS, et al. Intravitreal preservativefree triamcinolone acetonide for the treatment of macular oedema. Eye. 2005; 19:686-688.
30. McIntosh RL, Mohamed Q, Saw SM, et al. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007; 114:835-854.
31. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419-425.
32. Spandau U, Wickenhauser A, Rensch F, et al. Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand. 2007;85:118-119.
33. Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the Eye Disease Case-Control Study. Ophthalmology. 1998;105:765-771.
34. Hayreh SS, Klugman MR, Beri M, et al. Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Archive for Clin Exp Ophthalmol. 1999;228:201-217.
35. The Central Vein Occlusion Study. Baseline and early natural history report. Arch Ophthalmol. 1993;111:1087-1095.
36. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24:493-519.
37. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117:429-441.
38. Fekrat S, Finkelstein D. Venous Occlusive Disease. In: Regall CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease: The Essentials. New York: Thieme; 1999:117-132.
39. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol. 1994;42:109-132.
40. Janssen MC, den Heijer M, Cruysberg JR, et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thrombo Haemost. 2005;93:1021-1026.
41. Williamson TH. Central retinal vein occlusion: what's the story? BrJ of Ophthalmol. 1977;81:698-704.
42. Green WR, Chan CC, Hutchins GM, et al. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
43. Hayreh SS, Zimmerman MB, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603-624.
44. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology. 1979;86:1931-1942.
45. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. AmJ Ophthalmol. 1990;1 10:118-123.
46. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486-491.
47. Minturn J, Brown GC. Progression of nonischemic central retinal vein obstruction to the ischemic variant. Ophthalmology. 1986;93:1158-1162.
48. Sinclair SH, Gragoudas ES. Prognosis for rubeosis iridis following central retinal vein occlusion. BrJ Ophthalmol. 1979;63:735-743.
49. Kohner EM, Hamilton AM, Bulpitt CJ, et al. Streptokinase in the treatment of central retinal vein occlusion: a controlled trial. Trans Ophthalmol Soc UK. 1974;94: 599-603.
50. Kohner EM, Pettit JE, Hamilton AM, et al. Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br MedJ. 1976;1:550-553.
51. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471-504.
52. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 1994;232:33-39.
53. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol. 1989;73:895-899. (Pubitemid 20004003)
54. Luckie AP, Wroblewski JJ, Hamilton P, et al. A randomized prospective study of outpatient haemodilution for central retinal vein obstruction. Aust N Z J Ophthalmol. 1996;24:223-232.
55. Tewari HK, Sony P, Chawla R, et al. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. EurJ Ophthalmol. 2005;15:619-626.
56. Jonas JB, Akkoyun I, Kamppeter B, et al. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. EurJ Ophthalmol. 2005;15:751-758. (Pubitemid 43074702)
57. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004;122:1131-1136.
58. Williamson TH, O'Donnell A. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol. 2005;139:860-866.
59. Peyman GA, Kishore K, Conway MD. Surgical chorioretinal venous anastomosis for ischemic central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:605-614.
60. Mirshahi A, Roohipoor R, Lashay A, et al. Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial. BrJ Ophthalmol. 2005;89:64-69.
61. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina. 2004;24:348-355.
62. Sekiryu T, Yamauchi T, Enaida H, et al. Retina tomography after vitrectomy for macular edema of central retinal vein occlusion. Ophthalmic Surg Lasers. 2000;31: 198-202.
63. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408-415.
64. Hayreh SS, Opremcak EM, Bruce RA, et al. Radial optic neurotomy for central retinal vein obstruction (letter). Retina. 2002;22:374-377.
65. The Central Vein Occlusion Study group N. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report. Ophthalmology. 1995; 102:1434-1444.
66. The Central Vein Occlusion Study Group M. Evaluation of grid pattern photo-coagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology. 1995; 102:1425-1433.
67. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. AmJ Ophthalmol. 2007;144:864-871. (Pubitemid 350122344)
68. Stahl A, Agostini H, Hansen LL, et al. Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol. 2007;245:1429-1436.
69. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGFas a critical stimulator. Mol Ther: JAm Soc Gene Ther. 2008; 16:791-799.
70. Hayreh SS, Hayreh MS. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol. 1980;98:1600-1609.
71. Von Graefe A. Ueber Embolie der arteria centralis retinae als Urscahe plotzlicher Erblingdung. Arch fur Ophthalmol. 1859;5:136-157.
72. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol. 1999;128:733-738.
73. Brown GC, Magargal LE, Shields JA, et al. Retinal arterial obstruction in children and young adults. Ophthalmology. 1981;88:18-25.
74. Brown GC, Magaragal LE. Central retinal artery obstruction and visual acuity. Ophthalmology. 1982;89:14-19.
75. Ffytche TJ. A rationalization of treatment of central retinal artery occlusion. Trans Ophthalmol Soc United Kingdom. 1974;94:468-479.
76. Brown GC, Shields JA. Amaurosis fugax secondary to presumed cavernous hemangioma of the orbit. Ann Ophthalmol. 1981;12:1205-1209.
77. Sharma S, ten Hove MW, Pinkerton RMH, et al. Interobserver agreement in the evaluation of acute retinal artery occlusion. Can J Ophthalmol. 1997;32:441-444.
78. Brown GC, Shields JA. Cilioretinal arteries and retinal arterial occlusion. Arch Ophthalmol. 1979;97:84-92.
79. Sharma S, Grown GC, Cruess AF, for the RECO Study Group. The accuracy of visible retinal emboli for the detection of cardio-embolic lesions requiring antic-oagulation or cardiac surgery. BrJ Ophthalmol. 1998;82:655-658.
80. David NJ, Norton EWD, Gass JD, et al. Flourescein angiography in central retinal artery occlusion. Arch Ophthalmol. 1967;77:619-629.
81. Brown GC, Magaral LE. The ocular ischemic syndrome. Clinical, flourescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239-251.
82. Brown GC, Magaral LE, Sergott R. Acute obstruction of the retinal and choroidal circulations. Opthalmology. 1986;93:1373-1382.
83. Sharma S, Brown GC, Pater JL, et al. Does a visible retinal emboli increase the likelihood of hemodynamically significant carotid artery stenosis in patients with acute retinal artery occlusion? Arch Ophthalmol. 1998; 116:1602-1606.
84. Perraut LE, Zimmerman LE. The occurrence of glaucoma following occlusion of the central retinal artery. A clinicopatholgic report of six cases and a review of the literature. Arch Ophthalmol. 1959;61:845-865.
85. Caroll D. Retinal Migraine. Headache. 1970; 10:9-13.
86. Silberberg DH, Laties AM. Occlusive migraine. Trans Pa Acad Ophthalmol Otolayngol. 1974;27:34-38.
87. Gold D. Retinal artery occlusion. Trans Am Acad Ophthalmol Otolaryngol. 1977;83: 392-408.
88. Arruga J, Sanders MD. Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology. 1982;89:1336-1347.
89. Sharma S, Naqvi A, Sharma SM, et al, for RECO. Transthoracic echocardiographic finding in patients with acute retinal artery occlusion. Arch Ophthalmol. 1996;114:1189-1192.
90. Shah HG, Brown GC, Goldberg RE. Digital subtraction carotid angiography and retinal arterial obstruction. Ophthalmology. 1985;92:68-72.
91. Brown GC. Arterial occlusive disease. In: Regallo CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease: The Essentials. New York: Thieme; 1999:97-115.
92. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 1980;87:75-78.
93. Hayreh SS, Podhajsky R Ocular neovascularization with retinal vascular occlusion II. Occurrence in central and branch retinal artery occlusion. Arch Opthalmol. 1982;100:1585-1596.
94. Duker JS, Sivalingham A, Brown GC, et al. A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol. 1991;109:339-342.
95. Duker JS, Brown GC. Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology. 1988;95:1244-1249.
96. Duker JS, Brown GC. The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction. Ophthalmology. 1988;95: 1244-1249.
97. Duker JS, Brown GC. Neovascularization of the disc associated with obstruction of the central retinal artery. Ophthalmology. 1989;96:87-91.
98. Harino S, Grunwald JE, Petrig BJ, et al. Rebreathing into a bag increases human retinal macular blood velocity. BrJ Ophthalmol. 1995;79:380-383.
99. Schmetterer L, Lexer F, Findl O, et al. The effect of inhalation of different mixtures of O2 and CO2 on ocular fundus pulsations. Exp eye res. 1996;63:351-355. (Pubitemid 26366762)
100. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology. 1995;102:2029-2034.
101. Rassam SM, Patel V, Kohner EM. The effect of acetazolamide on the retinal circulation. Eye. 1993;7(Pt 5):697-702.
102. Harvey PA, Winder S, Talbot JF. Trabeculectomy for central retinal artery occlusion. Eye. 2000;14(Pt 2):256-257.
103. Neubauer AS, Mueller AJ, Schriever S, et al. Minimally invasive therapy for clinically complete central retinal artery occlusion - results and meta-analysis of literature (Minimal invasive Therapie bei klinisch komplettem Zentralarte-rienverschluss -eigene Ergebnisse und Literaturvergleich). Klin Monatsbl Augenheilkund. 2000;217: 30-36.
104. Iwafune Y, Yoshimoto H. Clinical use of pentoxifylline in haemorrhagic disorders of the retina. Pharmatherapeutica. 1980;2:429-438.
105. Kieswetter H, Korber N, Jung F, et al. Rheologic findings in patients with acute central retinal artery occlusion. Graefe's Arch Clin Exp Ophthalmol. 1983;220:92-95.
106. Hausmann N, Richard G. Effect of high dose steroid bolus on occlusion of ocular central artery: angiographic study. BMJ. 1991 ;303:1445-1446.
107. Fraser S, Siriwardena D. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. 2002;CD001989.
108. Brown GC, Reber R. An unusual presentation of branch retinal artery obstruction in association with ocular neovascularization. Can J Ophthalmol. 1986;21:103-106.
109. Rahman W, Rahman FZ. Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50:415-428.
110. Wilkinson I, Russell RW. Arteries of the head and neck in giant cell arteritis. Arch Neurol. 1972;27:378-391.
111. Carroll S, Gaskin BJ, Danesh-Meyer HV. Giant cell arteritis. Clin Exp Ophthalmol. 2006;34:159-173.
112. Liu G, Glaser JS, Schatz NJ, et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis of vision. Ophthalmology. 1994;101:1779-11185
113. Hayreh S, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. AmJ Ophthalmol. 1998; 125:509-520. (Pubitemid 28236919)
114. Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia rheumatica and giant-cell arteritis. N EnglJ Med. 2002;347:261-271.
115. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;1 13:1842-1845.
116. Susac JO, Hardimann JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology. 1979;29:313-316.
117. Susac JO. Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in women. Neurology. 1994;44:591-593.
118. Magro CM. Susac syndrome -an autoimmune endotheliopathy. Paper presented at the 1st Susac Symposium held at Ohio State University, Columbus, OH, April, 2005.
119. Susac JO, Egan RA, Rennebohm RM, et al. Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci. 2007;257(1-2):270-272.
120. Susac JO, Murtagh FR, Egan RA, et al. MRI findings in Susac's syndrome. Neurology. 2003;61:1783-1787.
121. Susac JO. Susac's syndrome. AmJ Neuroradiol. 2004;25:351-352.
122. Saenz R, Quan AW, Magalhaes A, et al. MRI of Susac's syndrome. Am J Radiol. 2005;184:1688-1690.
123. Egan RA, Nguyen TH, Gass DM, et al. Retinal arterial wall plaques in Susac syndrome. Am J Ophthalmol. 2003;135:483-486.
124. Kearns TP. Ophthalmology and the carotid artery. Am J Ophthalmol. 1979;55: 714-722.
125. Donnan GA, Sharbrough FW. Carotid occlusive disease. Effect of bright light on visual evoked response. Arch Neurol. 1982;39:687-689.
126. Foncea Beti N, Mateo I, Diaz La Calle V, et al. The ocular ischemic syndrome. Clin Neurol Neurosurg. 2003;106:60-62.
127. Sivalingham A, Brown GC, Magaragal LE, et al. The ocular ischemic syndrome II. Mortality and systemic morbidity. Int Ophthalmol. 1989;13:187-191.
128. Costa VP, Kuzniec S, Molnar LF, et al. The effect of carotid endarterectomy on the retrobulbar circulation of patients with severe occlusive carotid disease. An investigation by color Doppler imaging. Ophthalmology. 1999; 106:306-310.
129. Johnston ME, Gonder JR, Canny CL. Successful treatment of the ocular ischemic syndrome with panretinal photocoagulation and cerebrovascular surgery. Can J Ophthalmol. 1999;23:114-119.